KEYNOTES

Keynote speakers put forward big ideas, talk about their own experiences and offer advice on how students can make a mark on Canadian healthcare. Keynote topics and speaker bios will be revealed via our social media in the weeks leading up to the conference. Stay tuned!


43592911_10155846350261367_7304212260514168832_n.jpg

Steven Grover

FRIDAY, 8:30PM

Dr. Steven Grover is the Director of the McGill Comprehensive Improvement Program (CHIP) in Montreal and a Professor of Medicine at McGill University. His research interests include the importance of exercise, healthy eating, medication adherence and other lifestyle interventions to reduce the risk of cardiovascular disease, diabetes, and dementia. The validated disease simulation models, developed by his group, have been proven to improve patient care and knowing your “Cardiovascular Age” is now recommended by national treatment guidelines around the world. More recently, Steven has focused on the impact of web-based, e-health interventions on preventing disease and improving quality of life. This work has resulted in a number of e-health platforms including: The Cardiometabolic Age Calculator, nVIGORus, and myhealthcheckup (MHC). Steven is an avid but slow jogger, enjoys snowshoeing and skiing in winter, and walks everywhere in any weather. He has been happily married for over 37 years to his wife, Mara, who is also a physician. They have four sons who never listen to them and two dogs that occasionally do.


44693963_10155846350396367_1342836149458042880_n.jpg

Marcia Anderson

SATURDAY, 9:45AM

Dr. Marcia Anderson is Cree- Saulteaux and grew up in the North End of Winnipeg, with roots going to the Norway House Cree Nation and Peguis First Nation in Manitoba. She practices both Internal Medicine and Public Health as a Medical Officer of Health with the Winnipeg Regional Health Authority. She is the Executive Director of Indigenous Academic Affairs in the Ongomiizwin Indigenous Institute of Health and Healing, Rady Faculty of Health Sciences, University of Manitoba. Current active areas of work include leading the development and implementation of Truth and Reconciliation Response Action Plans, Indigenous youth health, and Indigenous health care quality. She serves as the Chair of the Indigenous Health Network of the Association of Faculties of Medicine of Canada and is a member of the Royal College of Physicians and Surgeons Indigenous Health Advisory Committee and PGME Implementation Committee. She is a Past President of the Indigenous Physicians Association of Canada and Past Chair of the Pacific Region Indigenous Doctors Congress. She was recognized for her contributions to Indigenous peoples health with a National Aboriginal Achievement Award in March 2011.

44789867_10155846350131367_5216672633545818112_o.jpg

Mark Henick

SUNDAY, 10:00AM

Mental Health Advocate & Strategist | Top 50 TEDx Speaker

Mark is currently the Principal and CEO of a boutique consulting firm that helps individuals, companies, and governments to move strategically from awareness to action in improving mental health and wellness. He was previously the National Director of Strategic Initiatives for the Canadian Mental Health Association (CMHA), and, prior to that, served as the youngest president of a provincial CMHA division in history, the youngest ever member of the board of directors for Canada’s Mental Health Commission, and as a national spokesperson for the Faces of Mental Illness campaign. He has also worked as a frontline mental health counsellor, and as the manager of a national workplace mental health training program.

Mark has appeared in hundreds of television, radio, print, and online media features on mental health. His work has been featured in such outlets as CTV National News, Entertainment Tonight, the Toronto Star, The New York Daily News, The Independent, The Daily Mail, The Huffington Post, and Reader’s Digest. He has had bylines with CNN, The Globe and Mail, The Montreal Gazette, and the Chicago Tribune, among others.

Mark holds a Master of Science in child development; a Bachelor of Arts with interdisciplinary honours in psychology and philosophy; and has certificates in trauma counselling, suicide intervention, non-violent crisis intervention, mental health first aid, and knowledge exchange.

44836586_10155846350446367_2395496663356538880_n.png

Michael Rauh

SUNDAY, 3:30PM

Dr. Rauh obtained his MD/PhD training at the University of British Columbia and Terry Fox Laboratory of the BC Cancer Agency. Residency training in Hematological Pathology was conducted at the University of Toronto. Dr. Rauh is an alumnus of the joint American Society of Hematology/European Hematology Agency Translational Research Training Program in Hematology (TRTH). Since 2011 he has been appointed as a Clinician-Scientist in the Department of Pathology at Queen’s University. His objective is to transform myeloid cancer practice and research by shifting the focus to the earliest genetic and immune alterations, leading to earlier detection, improved prognostics and targeted treatment. He has established a personalized myeloid pathology and research laboratory at Queen’s – QMyPath and has assembled a bedside-to-bench network of local, national and international collaborators. Dr. Rauh's lab was among the first to identify TET2 mutations as drivers of clonal hematopoiesis (CHIP), hyper-inflammatory macrophages and comorbidity in mice and humans. His related research experience with next-generation sequencing (NGS) has been instrumental in the early adoption of clinical myeloid NGS at Kingston Health Sciences Centre (KHSC). The basic and translational aspects of his research are now naturally shifting to population genetics, cancer surveillance and prevention, and optimization of risk factors and healthy aging. He has consulted for the Pediatric Oncology Group of Canada, Cancer Care Ontario and the Canadian Cancer Trials Group. His research has been supported by agencies including the Canada Foundation for Innovation (CFI), Southeastern Ontario Academic Medical Organization (SEAMO), University Hospitals Kingston Foundation (UHKF), Canadian Cancer Society Research Institute (CCSRI), the Ontario Institute for Cancer Research (OICR), and the Canadian Institutes of Health Research (CIHR).